Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Revenue

Hyloris Pharmaceuticals had revenue of 4.70M EUR in the half year ending June 30, 2026, with 13.07% growth. This brings the company's revenue in the last twelve months to 8.89M, up 21.33% year-over-year. In the year 2025, Hyloris Pharmaceuticals had annual revenue of 7.21M, down -14.79%. That makes Hyloris Pharmaceuticals the 36,854th largest company in the world by revenue and 92nd in Belgium.

• Revenue (ttm): 8.89M
• Revenue Growth: +21.33%
• P/S Ratio: 10.60
• Revenue / Employee: 181.98K
• Employees: 54
• Market Cap: 104.16M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.21M	-1.25M	-14.79%
Dec 31, 2024	8.46M	6.37M	305.27%
Dec 31, 2023	2.09M	1.19M	131.89%
Dec 31, 2022	900.00K	-2.20M	-70.93%
Dec 31, 2021	3.10M	2.92M	1,669.14%
Dec 31, 2020	175.00K	84.00K	92.31%
Dec 31, 2019	91.00K	-	-
Dec 31, 2018	91.00K	-122.00K	-57.28%
Dec 31, 2017	213.00K	-	-

Data Source: Fiscal.ai Last updated: Sep 24, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 10, 2026

Data Sources Report a data error